Terms: = Skin cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4
415 results:
1. Risk of cancer in patients with bile acid diarrhoea: a Danish nationwide matched cohort study.
Nyboe Andersen N; Wildt S; Iversen AT; Poulsen G; Jess T; Munck LK; Borup C
BMJ Open Gastroenterol; 2024 Apr; 11(1):. PubMed ID: 38688717
[TBL] [Abstract] [Full Text] [Related]
2. B7-H3 is associated with the armored-cold phenotype and predicts poor immune checkpoint blockade response in melanoma.
Shen B; Mei J; Xu R; Cai Y; Wan M; Zhou J; Ding J; Zhu Y
Pathol Res Pract; 2024 Apr; 256():155267. PubMed ID: 38520953
[TBL] [Abstract] [Full Text] [Related]
3. The Opioid Receptor Influences Circadian Rhythms in Human Keratinocytes through the β-Arrestin Pathway.
Bigliardi P; Junnarkar S; Markale C; Lo S; Bigliardi E; Kalyuzhny A; Ong S; Dunn R; Wahli W; Bigliardi-Qi M
Cells; 2024 Jan; 13(3):. PubMed ID: 38334624
[TBL] [Abstract] [Full Text] [Related]
4. Collision Enhanced Raman Scattering (CERS): An Ultra-High Efficient Raman Enhancement Technique for Hollow Core Photonic Crystal Fiber Based Raman Spectroscopy Gas Analyzer.
Shirmohammad M; Short MA; Zeng H
Biosensors (Basel); 2023 Nov; 13(11):. PubMed ID: 37998154
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of Cell Type Abundance and Gene Expression Timeline from Burned skin Bulk Transcriptomics by Deconvolution.
Fei X; Zhu M; Li X
J Burn Care Res; 2024 Jan; 45(1):205-215. PubMed ID: 37956340
[TBL] [Abstract] [Full Text] [Related]
6. Dynamics of Soluble Forms of the Immune Checkpoint Components PD-1/PD-L1/B7-H3, CD314/ULBP1, and HLA-G in Peripheral Blood of Melanoma Patients Receiving Blockers of Programmed Cell Death Protein PD-1.
Gershtein ES; Mochalova AS; Korotkova EA; Samoilova EV; Vashketova OI; Kuz'min YB; Sokolov NY; Kushlinskii NE
Bull Exp Biol Med; 2023 Aug; 175(4):481-486. PubMed ID: 37773572
[TBL] [Abstract] [Full Text] [Related]
7. Novel Anti-Melanoma Compounds Are Efficacious in A375 Cell Line Xenograft Melanoma Model in Nude Mice.
Velayutham S; Seerattan R; Sultan M; Seal T; Danthurthy S; Chinnappan B; Landi J; Pearl K; Singh A; Smalley KSM; Zaias J; Choi JY; Minond D
Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759675
[TBL] [Abstract] [Full Text] [Related]
8. 3-deazaneplanocin A, a histone methyltransferase inhibitor, improved the chemoresistance induced under hypoxia in melanoma cells.
Hosokawa M; Tetsumoto S; Yasui M; Kono Y; Ogawara KI
Biochem Biophys Res Commun; 2023 Oct; 677():26-30. PubMed ID: 37542772
[TBL] [Abstract] [Full Text] [Related]
9. IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment.
Elcheva IA; Gowda CP; Bogush D; Gornostaeva S; Fakhardo A; Sheth N; Kokolus KM; Sharma A; Dovat S; Uzun Y; Schell TD; Spiegelman VS
Front Immunol; 2023; 14():1224516. PubMed ID: 37503349
[TBL] [Abstract] [Full Text] [Related]
10. Ex vivo mapping of enhancer networks that define the transcriptional program driving melanoma metastasis.
Manicardi V; Gugnoni M; Sauta E; Donati B; Vitale E; Torricelli F; Manzotti G; Piana S; Longo C; Ghini F; Ciarrocchi A
Mol Oncol; 2023 Dec; 17(12):2728-2742. PubMed ID: 37408506
[TBL] [Abstract] [Full Text] [Related]
11. pH Switchable Nanozyme Platform for Healing skin Tumor Wound Infected with Drug-Resistant Bacteria.
Yan Y; Wang M; Zhao M; Zhang J; Liu Y; Gao X
Adv Healthc Mater; 2023 Nov; 12(28):e2301375. PubMed ID: 37399839
[TBL] [Abstract] [Full Text] [Related]
12. Hydrogen nanobubbles: A novel approach toward radio-sensitization agents.
Hashemi S; Aghamiri SM; Siavashpour Z; Kahani M; Zaidi H; Jaberi R
Med Phys; 2023 Oct; 50(10):6589-6599. PubMed ID: 37278345
[TBL] [Abstract] [Full Text] [Related]
13. Methyltransferase-independent function of enhancer of zeste homologue 2 maintains tumorigenicity induced by human oncogenic papillomavirus and polyomavirus.
Khattri M; Amako Y; Gibbs JR; Collura JL; Arora R; Harold A; Li MY; Harms PW; Ezhkova E; Shuda M
Tumour Virus Res; 2023 Dec; 16():200264. PubMed ID: 37244352
[TBL] [Abstract] [Full Text] [Related]
14. Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma.
Peng X; Yu Z; Surineni G; Deng B; Zhang M; Li C; Sun Z; Pan W; Liu Y; Liu S; Yu B; Chen J
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2201408. PubMed ID: 37096557
[TBL] [Abstract] [Full Text] [Related]
15. B7-H3 drives immunosuppression and Co-targeting with CD47 is a new therapeutic strategy in β-catenin activated melanomas.
Hsu M; Martin TC; Vyas NS; Desman G; Mendelson K; Horst B; Parsons RE; Celebi JT
Pigment Cell Melanoma Res; 2023 Sep; 36(5):407-415. PubMed ID: 37086018
[TBL] [Abstract] [Full Text] [Related]
16. Effects of folate on telomere length and chromosome stability of human fibroblasts and melanoma cells in vitro: a comparison of folic acid and 5-methyltetrahydrofolate.
Wang H; Ni J; Guo X; Xue J; Wang X
Mutagenesis; 2023 Jun; 38(3):160-168. PubMed ID: 36966355
[TBL] [Abstract] [Full Text] [Related]
17. Effects of folate on telomere length and chromosome stability of human fibroblasts and melanoma cells in vitro: a comparison of folic acid and 5-methyltetrahydrofolate.
Wang H; Ni J; Guo X; Xue J; Wang X
Mutagenesis; 2023 May; 38(2):100-108. PubMed ID: 36932659
[TBL] [Abstract] [Full Text] [Related]
18. NADK-mediated de novo NADP(H) synthesis is a metabolic adaptation essential for breast cancer metastasis.
Ilter D; Drapela S; Schild T; Ward NP; Adhikari E; Low V; Asara J; Oskarsson T; Lau EK; DeNicola GM; McReynolds MR; Gomes AP
Redox Biol; 2023 May; 61():102627. PubMed ID: 36841051
[TBL] [Abstract] [Full Text] [Related]
19. In Vivo Acute Toxicity Studies of Novel Anti-Melanoma Compounds Downregulators of hnRNPH1/H2.
Velayutham S; Seal T; Danthurthy S; Zaias J; Smalley KSM; Minond D
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830718
[TBL] [Abstract] [Full Text] [Related]
20. Screening costs associated with donor selection for fecal microbiota transplantation for treatment of PD-1 refractory melanoma patients.
Fortman D; Avellan MGP; Hurd D; Schwartz M; Dubner H; Hewitt C; Berton S; Ernst S; Rose A; Zarour HWH; Davar D
Melanoma Res; 2023 Apr; 33(2):136-148. PubMed ID: 36806616
[TBL] [Abstract] [Full Text] [Related]
[Next]
